Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study confirms efficacy of Infiltrator catheter:

This article was originally published in Clinica

Executive Summary

A trial of Interventional Technologies' Infiltrator drug delivery catheter has demonstrated the safety and feasibility of using the device to deliver dilute ethanol in patients with in-stent restenosis. The Beaumont Alcohol Restenosis Study (BARS), which is assessing the procedure as a treatment for preventing in-stent restenosis, evaluated 24 patients with clinical evidence of ischaemia and diffuse in-stent restenosis. The patients received 15% ethanol delivered via the Infiltrator catheter. Procedural success was 100%, according to the San Diego, California company, with no major adverse in-hospital cardiac events. The study will now assess a further 25 patients who will receive 30% ethanol.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075237

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel